Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

NCT06075927 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

CMV Infection
EBV Infection
Stem Cell Transplant

Interventions

BIOLOGICAL: Virus specific T cells

Sponsor

Peking University People's Hospital